4.2600
+0.3440
+(8.78%)
At close: January 10 at 5:32:26 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in EUR | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 2 | 5 | 6 |
| Avg. Estimate | 6.5M | 13.56M | 530.38M | 73.75M |
| Low Estimate | -- | -- | 520.7M | -- |
| High Estimate | 15.8M | 27.11M | 543.1M | 154.78M |
| Year Ago Sales | 22.6M | 12.37M | 53.8M | 530.38M |
| Sales Growth (year/est) | -71.24% | 9.57% | 885.84% | -86.09% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CVAC.VI | -- | -- | -- | -- |
| S&P 500 | 8.70% | 11.55% | 14.03% | 13.42% |
Upgrades & Downgrades
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 9/16/2024 |
| Maintains | JMP Securities: Market Outperform to Market Outperform | 8/16/2024 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 7/3/2024 |
| Downgrade | Leerink Partners: Outperform to Market Perform | 4/25/2024 |
| Reiterates | Guggenheim: Neutral | 4/5/2024 |
| Initiated | Guggenheim: Buy | 4/26/2021 |
Related Tickers
AYJ.HA Valneva SE
2.2060
+4.45%
INRLF Valneva SE
2.0900
0.00%
VLA.VI Valneva SE
2.2240
+4.81%
BNTC Benitec Biopharma Inc.
11.00
-0.54%
TTNP Titan Pharmaceuticals, Inc.
3.3400
-1.18%
PCVX Vaxcyte, Inc.
81.08
+0.02%
VRDN Viridian Therapeutics, Inc.
18.20
-4.96%
HOOK HOOKIPA Pharma Inc.
2.1500
+15.59%
MREO Mereo BioPharma Group plc
3.5500
-5.59%
RARE Ultragenyx Pharmaceutical Inc.
42.07
-3.62%